USPTO serial 97235261
C THE SIGNS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 26, 2023
- Examiner
- CAHILL, CLARE GALLAGHER
- Law office
- TMEG LAW OFFICE 104
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with C THE SIGNS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mary Margaret L. O'Donnell
Mary Margaret L. O'Donnell Blue Filament Law PLLC772 E. Maple RoadBirmingham, MI 48009United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; computer software platforms, recorded or downloadable for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; digital media, namely, downloadable audio and audiovisual recordings featuring information and advice relating to cancer risk, cancer diagnosis, cancer treatment and the clinical needs of patients; multi-platform digital tools, namely, downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; all of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions | ACTIVE | — |
| 035 | Data processing services in the field of healthcare; data management, namely, database management, computer data entry services; data processing services; database management; computer data entry services and data processing services; compilation of data for business purposes; automated data processing services; electronic data collection services for business purposes in the fields of medicine and healthcare; systematization of data in computer databases; collating of data in computer databases, namely, compilation and systemization of information into computer databases; market research data analysis; online data processing services; preparation of healthcare statistical data, namely, providing statistical healthcare information for business or commercial purposes; dissemination of data relating to healthcare, namely, providing business information in the field of healthcare, database processing services; data and database improvement, namely, updating and maintenance of data in computer databases; data and database enhancement, namely, updating and maintenance of data in computer databases; combining data from multiple sources into databases, namely, systemization of data in computer databases; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions | ACTIVE | — |
| 041 | Educational and training services relating to healthcare, namely, conducting training, workshops, classes in the field of healthcare; education services, namely, conducting training, workshops, classes in the field of healthcare; providing of training in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients, rendered through correspondence courses; teaching in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; arranging and conducting of conferences, seminars and training workshops in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; providing education in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients rendered through correspondence courses; educational services, namely conducting classes, workshops, seminars in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; vocational guidance; organisation of exhibitions for educational purposes; providing on-line electronic publications in the nature of books, magazines, brochures, leaflets in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions | ACTIVE | — |
| 042 | Information technology services for the pharmaceutical and healthcare industries, namely, providing information technology consulting services, and providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; software as a service (SaaS) services featuring software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; platform as a service (PaaS) services featuring computer software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software, software as a service (SaaS) services featuring software, platform as a service (PaaS) services featuring computer software platforms and online, non-downloadable software platforms all for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; providing temporary use of online non-downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; multi-platform digital tools, namely, providing temporary use of online non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; compilation of data, namely, compiling data for research purposes in the field of medical science and medical consultancy; database improvement, namely, maintenance of on-line databases for others; database enhancement, namely, maintenance of on-line databases for others; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions | ACTIVE | — |
| 044 | Healthcare; medical services; hospital services and medical clinics; medical assistance; nursing services; health screening services in the field of cancer; medical information; health care services in the nature of dissemination of data relating to healthcare, namely, providing a database in the field of cancer information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; advisory and consultancy services relating to all of the aforesaid and none of the aforesaid relating to the testing and screening of neurological conditions | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by C the Signs Limited
- Other trademarks owned by C the Signs Limited
- Other trademarks owned by C the Signs Limited
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named C THE SIGNS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 10, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 10, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 10, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 26, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 26, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 11, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 11, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 21, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 2, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 2, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 2, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 3, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 2, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 2, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 8, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2022 | TAEA | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED | — |
| Jun 15, 2022 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Jan 27, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 27, 2022 | NWAP | NEW APPLICATION ENTERED | — |